Key points
- BNB is hovering near its lower Bollinger Band, with MACD turning bearish; $585 is key support.
- DOGE struggles below mid-range resistance, with RSI dipping and MACD showing no recovery signs.
- SOL faces downward pressure after a bearish crossover; $134 is the next critical support zone.
- SUI is holding above its mid-Bollinger band, but momentum is cooling off quickly.
Major altcoins are approaching decisive technical levels this week, with tightening Bollinger Bands, neutral RSI readings, and mixed MACD signals suggesting a potential shift in momentum.
Meanwhile, the broader market appears to be entering a consolidation phase, amid reduced volatility and fading trend strength.
In today’s technical scan, Binance Coin (BNB), Dogecoin (DOGE), Solana (SOL), and SUI were analyzed on the daily timeframe using standard indicators — including 10-day RSI, Bollinger Bands, and MACD — to assess short-term price direction.
BNB: Sideways Drift Hints at Looming Breakout
BNB continues to trade in a narrow range between the 20-day moving average and the lower Bollinger Band, with volatility compressing noticeably.
The 10-day RSI has dropped to 48.3 — suggesting momentum is fading, though not yet oversold. Meanwhile, the MACD lines have crossed bearishly, with the histogram shifting into negative territory.
A loss of the $585 level — the lower Bollinger Band — could expose BNB to further downside toward $553.
On the other hand, reclaiming $613 could mark a bullish reversal. Until then, the asset appears locked in a consolidation phase.
Price: $595 | Change: -2.09% | Support/Resistance: $585 / $613 | Prediction: Likely range-bound; breakdown could lead to $553, upside capped near $625.
DOGE: Fading Strength Keeps Bears in Control
Dogecoin’s structure remains weak, with price action trending sideways and RSI dropping to 41.3.
The meme token failed to hold above the midline of the Bollinger Bands and is now hovering close to its lower bound. The MACD has turned slightly negative, with the signal line now above the MACD line — reflecting weakening bullish momentum.
A sustained drop below $0.1527 could lead to accelerated downside toward the $0.14 region. For buyers to regain control, DOGE must push back above the $0.1720 resistance — a level that has repeatedly capped recent upside attempts.
Price: $0.1662 | Change: -2.56% | Support/Resistance: $0.152 / $0.172 | Prediction: Bearish outlook; a drop below $0.152 may lead to $0.14.
SOL: Momentum Slips as Key Support Nears
Solana has seen its bullish structure degrade further, with the RSI slipping to 49.8 and MACD confirming a bearish crossover. The price is now testing the midline of the Bollinger Bands, with lower support around $134 emerging as the next critical level
While a short-term bounce remains possible if the lower Bollinger Band holds, the technical setup points toward an increased likelihood of continued corrective movement. Only a close back above $145.3 would invalidate this bearish bias.
Price: $143.58 | Change: -2.13% | Support/Resistance: $134 / $145.3 | Prediction: Weak momentum may push SOL toward $134–$130 unless $145 is reclaimed soon.
SUI: Sharp Pullback After Overbought Spike
SUI’s recent surge above $4.00 was met with aggressive selling pressure, pushing the RSI down from overbought territory (75.3) to 56.8. The price remains above the midline of the Bollinger Bands, currently near $3.05, which now acts as the first major support.
Although MACD remains in bullish territory, the histogram is narrowing, showing declining momentum. A close below $3.05 could usher in a deeper pullback, while a bounce above $3.60 would revive bullish sentiment.
Price: $3.268 | Change: -4.49% | Support/Resistance: $3.05 / $3.60 | Prediction: Holding above $3.05 keeps bullish bias alive; break below could trigger a slide toward $2.90.
All content provided here is for informational purposes only and does not constitute financial or trading advice. Trading involves risk and may result in financial loss. We strongly recommend consulting a licensed advisor before making any investment decisions.
